Your search TAK 599 did not match any manufacturers. You may consider to:
Check the spelling
Use less keywords
Use different keywords
TAK 599 suppliers
TAK 599
- CAS:
- 400827-46-5
- MF:
- C24H25N8O10PS4
- MW:
- 744.72
Suppliers by country/region
Company Type
Properties
- storage temp.
- Store at -20°C
- solubility
- DMSO : 30 mg/mL (40.28 mM; Need ultrasonic and warming)
- form
- Powder
- color
- White to light yellow
Safety Information
Use
Ceftaroline fosamil, also referred to as TAK-599, is a cephalosporin antibacterial agent that was approved in the United States in October 2010 for the IV treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP). Ceftaroline fosamil is the water-soluble, N-phosphono prodrug of ceftaroline (T-91825), a broad-spectrum, bactericidal agent with potent activity against methicillin-resistant Staphylococcus aureus (MRSA) strains, multidrug resistant S. pneumonia, and common gram-negative organisms. Ceftaroline binds to PBP2a as well as other PBPs with high affinity and, as a result, retains potent activity. Ceftaroline exhibits activity against most gram-positive pathogens, including β-lactam-susceptible and -resistant S. aureus, vancomycin-resistant S. aureus, and resistant and susceptible forms of S. pneumoniae but has weak activity against Enterococcus sp. The gram-negative antibacterial activity of ceftaroline is limited mainly to respiratory pathogens such as Moraxella catarrhalis and Haemophilus influenzae.
Your search TAK 599 did not match any manufacturers. You may consider to: